Recently, CHU Pharma (Xi’an) Pharmaceutical Technology Co., Ltd. announced the official launch of export business for narcotic and psychotropic drugs, expanding its global pharmaceutical product portfolio and accelerating its international layout.

Narcotic and psychotropic drugs are strictly controlled special medicines in China, widely applied in clinical pain relief, sedation and anesthesia, playing a vital role in global healthcare systems. The company will strictly comply with Chinese and international regulatory requirements for import and export of controlled substances, and build a full‑process compliance management system covering registration, qualification, supply chain and export licensing to ensure all operations are legally compliant.

Leveraging its mature pharmaceutical foreign‑trade experience, the new business will focus on Belt‑and‑Road markets including Africa and Central Asia. We aim to deliver compliant and reliable supply solutions of narcotic and psychotropic drugs for overseas medical institutions and support local healthcare development.

Moving forward, CHU Pharma will keep deepening overseas pharmaceutical export business, enrich product pipelines, and expand more high‑value pharmaceutical categories on the basis of strict compliance, to promote Chinese pharmaceutical products to the world.